Lindynette

Ethinylestradiol / Gestodene, the active ingredient in Lindynette, is a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception to prevent pregnancy in women of reproductive age by suppressing ovulation and altering cervical mucus.

GNH USA supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across EU and global markets. The product meets EU pharmacopoeia standards and is manufactured under GMP conditions.

Lindynette, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual management.

- Prevention of pregnancy: provides effective contraception for women of childbearing potential. - Regulation of menstrual cycles: helps achieve more predictable bleeding patterns and reduces menstrual flow. - Management of dysmenorrhea: alleviates painful menstrual cramps associated with ovulatory cycles.

Lindynette may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Breast tenderness: discomfort or swelling of the breasts. - Headache: mild to moderate intensity, may improve with continued use. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Weight fluctuation: modest changes in fluid retention. - Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden increase in blood pressure. - Liver dysfunction: jaundice or hepatic adenoma. - Allergic reactions: rash, angioedema, or anaphylaxis.

Before prescribing Lindynette, consider the following precautions and warnings.

- Contraindicated in pregnancy: avoid use in women who are or may become pregnant. - Smoking over age 35: increased risk of cardiovascular events; advise cessation. - History of thromboembolism: avoid in patients with prior clotting disorders. - Liver disease: use with caution in hepatic impairment. - Hypertension: monitor blood pressure regularly. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lindynette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, phenytoin, carbamazepine, St. John's wort): may reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin): hormonal component can alter INR levels. - Certain HIV protease inhibitors: may increase hormone concentrations, raising risk of side effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase risk of mood changes. - Antihypertensives: possible reduction in blood‑pressure control. - Digoxin: slight increase in serum levels. - Anticonvulsants (valproate): may affect hormone metabolism. - Antibiotics (macrolides, tetracyclines): generally safe but monitor for breakthrough bleeding.